Lupski J R, Pentao L, Williams L L, Patel P I
Institute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
Am J Med Genet. 1993 Jan 1;45(1):92-6. doi: 10.1002/ajmg.1320450122.
Charcot-Marie-Tooth disease type 1A (CMT1A) was recently demonstrated to be associated with a large DNA duplication in 17p11.2p12. The gene for neurofibromatosis type 1 (NF1) or von Recklinghausen disease maps to 17q11.2. We have identified 2 unrelated patients who were diagnosed with both CMT1 and NF1. Molecular analysis of these patients demonstrated the presence of the CMT1A duplication and inheritance of this DNA rearrangement from a parent affected with CMT. Analysis of genomic DNA isolated from the neurofibroma removed from one of these patients showed the same 500 kb SacII junction fragment associated with the CMT1A duplication that was found in genomic DNA isolated from the blood. These results lend further support to the hypothesis that the CMT1A duplication is a stable DNA rearrangement. In addition, the molecular analysis of these 2 patients suggests that 2 common autosomal dominant conditions (CMT1 and NF1) can occur in the same individual, not because of an underlying single molecular defect, but rather, secondary to a chance phenomenon.
1型遗传性运动感觉神经病A亚型(CMT1A)最近被证实与17p11.2p12区域的大片段DNA重复有关。1型神经纤维瘤病(NF1)或冯雷克林霍增氏病的基因定位于17q11.2。我们发现了2例不相关的患者,他们同时被诊断患有CMT1和NF1。对这些患者的分子分析表明存在CMT1A重复,且这种DNA重排是从患有CMT的父母那里遗传而来的。对从其中一名患者切除的神经纤维瘤中分离出的基因组DNA进行分析,结果显示与CMT1A重复相关的500 kb SacII连接片段,与从血液中分离出的基因组DNA中发现的片段相同。这些结果进一步支持了CMT1A重复是一种稳定的DNA重排这一假说。此外,对这2例患者的分子分析表明,两种常见的常染色体显性疾病(CMT1和NF1)可出现在同一个体中,并非由于潜在的单一分子缺陷,而是继发于一种偶然现象。